CYRX
CryoportยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CYRX Profile
Cryoport, Inc.
A global leader in temperature-controlled supply chain solutions for the life sciences industry supporting life-saving cell and gene therapies across the clinical and commercial spectrum
Healthcare Equipment and Supplies
05/25/1990
07/23/2015
NASDAQ Stock Exchange
1,090
12-31
Common stock
112 Westwood Place, Suite 350, Brentwood, TN 37027
--
Cryoport, Inc., originally incorporated in Nevada on May 25, 1990 under the name GT5- Limited (GT5), changed its name to Cryoport Corporation on March 15, 2005. The company is a global leader in cell and gene therapy supply chain solutions that enable manufacturers, contract manufacturers (CDMOs), contract research organizations (CROs), developers and researchers to carry out their respective businesses. The company provides a wide range of supply chain solutions for the life science industry. Through the company platform of key products and solutions including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services and cryogenic systems, the company is "Enabling the Future of MedicineTM" to achieve superior supply chain management through the company's innovative systems, compliant procedures and agile approach on a global scale.
